5 Results for "

ATR-IN-33

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "ATR-IN-33" in MCE Product Catalog:

Cat. No.: HY-161616
CAS No.: 3010273-13-6
Target:  

ATM/ATR

Research Areas:  

Cancer

ATR-IN-30 is a selective ATR ligand, and can be used for synthesis of ATR PROTACs, such as PROTAC ATR degrader-2 (HY-161615) .
loading...
    loading...
Cat. No.: HY-171745
CAS No.: 2902715-97-1
Target:  

ATM/ATR

Research Areas:  

Cancer

ATR-IN-32 is an orally active ATR inhibitor. ATR-IN-32 potently inhibits the proliferation of MIA PaCa-2 cells. ATR-IN-32 exerts significant tumor growth inhibition in mice bearing LOVO and HT-29 xenografts. ATR-IN-32 can be used for the study of cancers mediated by ATR protein kinase, such as colorectal cancer, pancreatic cancer .
loading...
    loading...
Cat. No.: HY-149952
CAS No.: 2923800-62-6
Target:  

ATM/ATR

Research Areas:  

Cancer

ATR-IN-23 (Compound 34) is a potent and selective ATR inhibitor with an IC50 of 1.5 nM. ATR-IN-23 has potent antiproliferative effects on LoVo cells and synthetic lethality on HT-29 cells, and can be used in the study of DNA damage response (DDR)-deficient cancers .
loading...
    loading...
Cat. No.: HY-147565
CAS No.: 2758113-84-5
Target:  

ATM/ATR

Research Areas:  

Cancer

ATR-IN-13 (compound A9) is a potent ATR kinase inhibitor, with an IC50 of 2 nM. ATR-IN-13 can be used for ATR kinase mediated diseases research, such as proliferative diseases and cancer .
loading...
    loading...
Cat. No.: HY-172247
CAS No.: 2954923-16-9
Target:  

ATM/ATR

Research Areas:  

Cancer

ATR-IN-31 is a selective ATR kinase inhibitor with an IC50 of 7 nM. ATR-IN-31 does not significantly inhibit ATM kinase activity. ATR-IN-31 inhibits viability of prostate cancer cells.ATR-IN-31 can be used for the research of prostate cancer .
loading...
    loading...